The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

CEO Bill Sibold hailed 2024 as a "transformational year" for Madrigal Pharmaceuticals, but Wall Street isn't as enthusiastic ...

Are you an Ozempic user, or considering starting on the drug? You may want to read this. Recent research is cause for concern ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 463.56% and ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

The remainder took a placebo pill manufactured to look the same. After four weeks, two independent examiners found a slight increase in height among those taking the supplement. There was no ...

AbbVie closed out the year on a high note, as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s ...

President-elect Donald Trump's HHS appointees represent a broad spectrum of healthcare perspectives and are poised to significantly influence public health, pharmaceuticals and health systems.   With ...

From loss of skin elasticity to hair density, supplements that offer targeted support for GLP-1 users, as well as those that ...

Unable to fetch the weather details. Please try again.